StonvexLoading…
StonvexStonvexStonvexCore line items from FLNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $208.76M | $254.62M | $298.40M | $361.13M |
Operating Income | $-20.32M | $-23.66M | $-60.13M | $-119.59M |
Net Income | $-27.17M | $-29.28M | $-63.22M | $-123.33M |
EPS (Diluted) | $-1.05 | $-1.80 | $-4.59 | $-1.51 |
Total Assets | $89.13M | $93.62M | $111.87M | $183.97M |
Total Liabilities | $70.92M | $68.66M | $77.46M | $90.01M |
Cash & Equivalents | $12.94M | $9.44M | $15.80M | $25.55M |
Free Cash Flow OCF − CapEx | $-1.54M | $-14.12M | $8.11M | $1.95M |
Shares Outstanding | 29.64M | 20.02M | 13.62M | 80.09M |